Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre

被引:36
作者
Macdonald, Virginia [1 ,2 ]
Dore, Gregory J. [3 ]
Amin, Janaki [3 ]
van Beek, Ingrid [1 ,2 ]
机构
[1] S Eastern Sydney, Kirketon Rd Ctr, Sydney, NSW 2011, Australia
[2] Illawarra Area Hlth Serv, Sydney, NSW 2011, Australia
[3] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia
关键词
D O I
10.1071/SH06008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: In Australia, rates of hepatitis B (HBV) transmission continue to be higher in certain populations, including commercial sex workers and injecting drug users (IDU). This study aims to identify rates and predictors of completion of a HBV vaccination schedule in 'high-risk' attendees of a primary health care centre in Sydney. Methods: All clients who attended Kirketon Road Centre, a primary health care centre located in Kings Cross, Sydney, with no evidence of HBV immunity were included in the cohort. The study design was observational with historical controls. The main outcome measure was completion of a three-dose HBV vaccine schedule in the study period. Results: Among 2085 clients who received a first vaccination, 10 13 (49%) received a second and 435 (21%) received a third vaccination. Univariate analysis found that significant predictors of completion of the vaccine schedule were intention to administer an accelerated schedule (OR 1.49, P = 0.004), not being an IDU (OR 1.29, P = 0.02) and shorter time between first visit and first vaccine dose (OR 1.24, P for trend <0.0001); however, on multivariate analysis, not being an IDU was no longer a predictor of vaccine completion. Conclusion: Implementation of an accelerated vaccination schedule improved completion rates but they were still low, despite the provision of free vaccination in a service specifically targeting the needs of sex workers, IDU and other marginalised populations. Increasing HBV vaccine uptake and completion rates in Australian adults is an important public health issue not only for the prevention of HBV but also for the future application of other potential vaccines, including those against HIV and hepatitis C.
引用
收藏
页码:27 / 30
页数:4
相关论文
共 21 条
[1]   HEPATITIS-B VIRUS-INFECTION AND VACCINATION STATUS OF HIGH-RISK PEOPLE IN SYDNEY - 1982 AND 1991 [J].
ANDERSON, B ;
BODSWORTH, NJ ;
ROHRSHEIM, RA ;
DONOVAN, BJ .
MEDICAL JOURNAL OF AUSTRALIA, 1994, 161 (06) :368-371
[2]   Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995 [J].
Crofts, N ;
Aitken, CK .
MEDICAL JOURNAL OF AUSTRALIA, 1997, 167 (01) :17-20
[3]  
Day C, 2003, AUST NZ J PUBL HEAL, V27, P558
[4]   EARLY ANTI-HBS ANTIBODY-RESPONSE TO ACCELERATED AND TO CONVENTIONAL HEPATITIS-B VACCINATION REGIMENS IN HEALTHY-PERSONS [J].
HARRIES, AD ;
CLARK, M ;
BEECHING, NJ ;
LAVELLE, J ;
MUTTON, KJ .
JOURNAL OF INFECTION, 1991, 23 (03) :251-254
[5]   The incidence of hepatitis B infection in Australia: An epidemiological review [J].
Kaldor, JM ;
Plant, AJ ;
Thompson, SC ;
Longbottom, H ;
Rowbottom, J .
MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (06) :322-326
[6]   Global control of hepatitis B virus infection [J].
Kao, JH ;
Chen, DS .
LANCET INFECTIOUS DISEASES, 2002, 2 (07) :395-403
[7]   Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia [J].
Maher, L ;
Chant, K ;
Jalaludin, B ;
Sargent, P .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (10) :1114-1120
[8]   3-WEEK HEPATITIS-B VACCINATION PROVIDES PROTECTIVE IMMUNITY [J].
MARCHOU, B ;
PICOT, N ;
CHAVANET, P ;
AUVERGNAT, JC ;
ARMENGAUD, M ;
DEVILLIERS, P ;
CERISIER, JE ;
MARIE, FN ;
EXCLER, JL .
VACCINE, 1993, 11 (14) :1383-1385
[9]   Factors influencing hepatitis B vaccine uptake in injecting drug users [J].
McGregor, J ;
Marks, PJ ;
Hayward, A ;
Bell, Y ;
Slack, RCB .
JOURNAL OF PUBLIC HEALTH MEDICINE, 2003, 25 (02) :165-170
[10]   Occult hepatitis B virus infection in a North American adult Hemodialysis patient population [J].
Minuk, GY ;
Sun, DF ;
Greenberg, R ;
Zhang, M ;
Hawkins, K ;
Uhanova, J ;
Gutkin, A ;
Bernstein, K ;
Giulivi, A ;
Osiowy, C .
HEPATOLOGY, 2004, 40 (05) :1072-1077